Rabeprazole clinical trials
Also written Aciphex, Pariet and E3810.
How each study uses Rabeprazole is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Rabeprazole studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 19 Aug 1999 · ACIPHEX · NDA 020973 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
102 studies that test it; most in 2005 (10)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 5 |
| 2004 | 6 |
| 2005 | 10 |
| 2006 | 5 |
| 2007 | 3 |
| 2008 | 9 |
| 2009 | 6 |
| 2010 | 9 |
| 2011 | 7 |
| 2012 | 2 |
| 2013 | 6 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 64 · Other 41
Eisai Inc. (12) · Eisai Co., Ltd. (9) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (6) · Pfizer (4) · GlaxoSmithKline (3) · The Catholic University of Korea (3) · Lomond Therapeutics Holdings, Inc. (2) · Genentech, Inc. (2)
Often tested with
Tested in the same studies.
Amoxicillin (10) · Clarithromycin (8) · Itraconazole (4) · E-3810 (4) · Metronidazole (4) · Famotidine (3) · Palbociclib (3) · Pantoprazole (3)
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 1 phase 3 study under way
Rabeprazole is the comparator. A study of two new drugs counts under both.
- 1Vonoprazan · King George's Medical University
Reaching primary completion within a year · 1
Studies that test Rabeprazole.
- Dec 2026Study to Evaluate the Effect of Rabeprazole Sodium Enteric-coated Tablets on the Pharmacokinetics of TQ05105 TabletsPhase 1 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Studies
Open first, then newest update. How each study uses Rabeprazole is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 105
- Efficacy And Safety of Bismuth-Tetracycline-Rabeprazole Triple For First-Line Eradication of Helicobacter Pylori InfectionNot yet recruitingNot applicableChih-An Shih, MDNCT07788053Written as Bismuth quadruple therapy
- Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRventionRecruitingPhase 4Yonsei UniversityNCT07471867Written as Rabeprazole
- Zuojin Wan Combined With Rabeprazole or Mosapride for the Treatment of Functional Dyspepsia Combined With DepressionNot yet recruitingNot applicableNanjing First Hospital, Nanjing Medical UniversityNCT06481371Written as Rabeprazole sodium enteric-coated tablets
- Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese SubjectsCompletedPhase 2Nantes University HospitalNCT01136317Written as Rabeprazole
- Study to Evaluate the Effect of Rabeprazole Sodium Enteric-coated Tablets on the Pharmacokinetics of TQ05105 TabletsActive, not recruitingPhase 1Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT07608666Written as Rabeprazole sodium enteric-coated tablets
- Evaluate the Effects of Famotidine or Rabeprazole on the PK of NirogacestatCompletedPhase 1SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, GermanyNCT07171619Written as Nirogacestat and Rabeprazole
- Study of Single and Multiple Ascending Doses of ZE46-0134 in Healthy VolunteersCompletedPhase 1Lomond Therapeutics Holdings, Inc.NCT06399315Written as Rabeprazole, 20mg oral
- Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy VolunteersCompletedPhase 1Lomond Therapeutics Holdings, Inc.NCT06787131Written as Rabeprazole 20 mg
- A Study in Healthy Men to Compare Two Different Oral Formulations of BI 1810631 and to Test How Food or Rabeprazole Influence the Amount of BI 1810631 in the BloodCompletedPhase 1Boehringer IngelheimNCT05380947Written as Rabeprazole sodium
- Helicobacter Pylori Infection and Gastric Disease in Bhutan: First Community-Wide, Population-Based StudyCompletedNot applicableZero Helicobacter IGAN NetworkNCT07211880Written as Rabeprazole Sodium, Amoxicillin Hydrate, Clarithromycin
- A Study of Maribavir Pediatric Formulation in Healthy Adult ParticipantsCompletedPhase 1TakedaNCT05918822Written as Rabeprazole
- Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer DiseasesCompletedNot applicableJiangxi University of Traditional Chinese MedicineNCT03320538Written as Rabeprazole
- Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00649493Written as Rabeprazole Sodium Tablets 20 mg
- HMPL-689 Drug Interaction Study With CYP3A Inhibitor/CYP2C9 Inhibitor/CYP3A Inducer/PPICompletedPhase 1HutchmedNCT05602597Written as Rabeprazole 40 mg
- A Relative Bioavailability Study Evaluating Two New Encorafenib FormulationsCompletedPhase 1PfizerNCT05446142Written as Rabeprazole tablet
- A Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of YPI 011 to Rabeprazole in Healthy Adult SubjectsCompletedPhase 1Yungjin Pharm. Co., Ltd.NCT04703868Written as Rabeprazole Sodium 10mg
- A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin CapsulesCompletedPhase 1/2TenNor Therapeutics (Suzhou) LimitedNCT06076681Written as Rabeprazole Sodium
- Personalized Treatment for Refractory H Pylori InfectionCompletedNot applicableKaohsiung Veterans General Hospital.NCT02547025Written as rabeprazole+3 antibiotics
- A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease PatientsCompletedPhase 3Eisai Co., Ltd.NCT02135107Written as Rabeprazole
- Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)CompletedPhase 3Eisai Inc.NCT00838526Written as Rabeprazole ER
See all 105 studies that test Rabeprazole →
Given beside what is tested · 44 — Rabeprazole is usual care or a partner of the new treatment
- Assessing the Effect of a Proton Pump Inhibitor on the Pharmacokinetics of DZD8586 in Healthy Participants (TAI-SHAN21)RecruitingPhase 1Dizal PharmaceuticalsNCT07888569Written as Rabeprazole
- Helicobacter Pylori Eradication and Follow-upRecruitingPhase 4Shanghai Zhongshan HospitalNCT05061732Written as Rabeprazole
- A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy AdultsCompletedPhase 1PfizerNCT07597928Written as Rabeprazole
- A Study on the Effect of Food and Proton Pump Inhibitor on the Pharmacokinetics of HMPL-760 CapsulesCompletedPhase 1HutchmedNCT07643272Written as Rabeprazole and HMPL-760
- A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Medicine PF-08049820 in Healthy Chinese Adults.CompletedPhase 1PfizerNCT07284173Written as Rabeprazole
- Comparing the Extent to Which Three Different Formulations of LY4100511 (DC-853) Are Made Available in the Body, Alone and in the Presence of a Drug That Reduces Stomach AcidTerminatedPhase 1Eli Lilly and CompanyNCT06916143Written as Rabeprazole
- A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid TumorsCompletedPhase 1/2Bristol-Myers SquibbNCT05407675Written as Rabeprazole
- Efficacy and Safety of Rifasutenizol (TNP 2198), Rabeprazole and Amoxicillin in Participants With H. Pylori InfectionCompletedPhase 3TenNor Therapeutics (Suzhou) LimitedNCT05857163Written as Rabeprazole sodium enteric-coated tablets
- Study to Evaluate Safety, Drug Levels, Food and Relative Bioavailability of BMS-986365 in Healthy Adult Male ParticipantsCompletedPhase 1CelgeneNCT06417229Written as Rabeprazole
- A Study to Investigate the Effect of Increased Gastric pH on the Oral Bioavailability of the Orexin-2 Receptor Antagonist JNJ-42847922 in Healthy ParticipantsCompletedPhase 1Janssen Research & Development, LLCNCT02475161Written as Rabeprazole
- Evaluation of the Effect of Rifampin and Rabeprazole on the Pharmacokinetics of CamlipixantCompletedPhase 1Bellus Health Inc. - a GSK companyNCT05899829Written as Rabeprazole
- The Safety and Tolerability, Pharmacokinetics of TNP-2092 Capsules in Combination With Rabeprazole Sodium Enteric-coated TabletsCompletedPhase 1TenNor Therapeutics Inc.NCT06337604Written as Rabeprazole sodium enteric-coated tablets
- Bioavailability of GDC-0134 and the Effect of Food and Proton Pump Inhibitor on Pharmacokinetics of GDC-0134 in Healthy Female ParticipantsCompletedPhase 1Genentech, Inc.NCT03237741Written as rabeprazole
- Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules in Helicobacter Pylori Infected-positive ParticipantsCompletedPhase 2TenNor Therapeutics (Suzhou) LimitedNCT06076694Written as Rabeprazole Sodium
- HMPL-453 Food Effect and PPI Study in Healthy Volunteer StudyCompletedPhase 1HutchmedNCT05930119Written as Rabeprazole
- Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori InfectionStatus unknownPhase 4Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT05718609Written as Rabeprazole
- HMPL-523 Food Effect and Proton Pump Inhibitor StudyCompletedPhase 1HutchmedNCT05571787Written as Rabeprazole
- Efficacy and Safety of Dual Therapy as First-line Treatment for Hp InfectionStatus unknownPhase 4Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT05419674Written as Rabeprazole
- Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to RabeprazoleWithdrawnPhase 4Xijing Hospital of Digestive DiseasesNCT02986685Written as rabeprazole
- Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple TherapyCompletedPhase 4Xijing Hospital of Digestive DiseasesNCT04697186Written as Rabeprazole
Showing 20 of 44.
As the comparator · 13 — what is tested is compared with Rabeprazole
- Comparison of Rabeprazole and Vonoprazan in the Prevention of Post-endoscopic Variceal Ligation Ulcer in Patients With CirrhosisNot yet recruitingPhase 3King George's Medical UniversityNCT07608536Written as Rabeprazol
- Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy, Vonoprazan-amoxicillin Dual Therapy and Proton Pump Inhibitor-based Standard Triple Therapy for Hp EradicationRecruitingNot applicableKaohsiung Medical UniversityNCT06349486Written as rabeprazole, amoxicillin, clarithromycin
- Efficacy and Safety of Keverprazan-amoxicillin Dual Therapy for Helicobacter Pylori First-line TreatmentRecruitingPhase 4Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT07122024Written as Rabeprazole
- Food Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Tablets 20 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00649194Written as Aciphex® Tablets 20 mg
- Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line EradicationCompletedPhase 4Xijing Hospital of Digestive DiseasesNCT05014334Written as Rabeprazole
- A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux EsophagitisStatus unknownPhase 2Xuanzhu Biopharmaceutical Co., Ltd.NCT05604261Written as Rabeprazole sodium 20 mg
- A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori GastritisStatus unknownPhase 4Changi General HospitalNCT03908619Written as Rabeprazole Sodium 20mg
- A Phase 2 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.CompletedPhase 2Sihuan Pharmaceutical Holdings Group Ltd.NCT04503629Written as Rabeprazole sodium
- Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.CompletedPhase 4Il-Yang Pharm. Co., Ltd.NCT02638584Written as Rabeprazole
- A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.Status unknownPhase 3Sihuan Pharmaceutical Holdings Group Ltd.NCT04215653Written as Rabeprazole
- Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated TabletsCompletedPhase 4Neutec Ar-Ge San ve Tic A.ŞNCT03037606Written as Pariet 20 mg Enteric Coated Tablets
- To Evaluate Efficacy and Safety of Z-215 in Erosive EsophagitisCompletedPhase 2Zeria PharmaceuticalNCT02463643Written as Rabeprazole Sodium
- Ilaprazole for the Treatment of Duodenal Ulcer in Chinese PatientsCompletedPhase 2/3Livzon Pharmaceutical Group Inc.NCT02847455Written as 10 mg Rabeprazole
Codes
What other systems call Rabeprazole · ClinicalTrials.gg INT008978
- MeSH (NLM) D064750RabeprazoleConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 32828355LLRABEPRAZOLEConfirmed FDA, NLM, Wikidata
- RxNorm 114979Confirmed FDA, Wikidata
- Wikidata Q3515(RS)-rabeprazoleConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29410RabeprazoleOne source FDA
- DrugBank DB01129One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D064750 | Rabeprazole | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 32828355LL | RABEPRAZOLE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 114979 | — | Confirmed FDA, Wikidata |
| Wikidata | Q3515 | (RS)-rabeprazole | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29410 | Rabeprazole | One source FDA |
| DrugBank | DB01129 | — | One source Wikidata |
Also registered as dexrabeprazole (UNII 65JK8810RM) and rabeprazole sodium (UNII 3L36P16U4R · RxNorm 226868).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.